The landscape of dementia diagnosis has evolved drastically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology years before indications arise. Although these technological advances stand for amazing progress in knowing neurodegenerative diseases, they may have not https://fredc198epb9.iyublog.com/profile